Schisandra chinensis (magnolia berry)

Schisandra chinensis is a plant whose extract is added to supplements as an adaptogen and marketed for improving athletic endurance. Convincing benefit for this use has not been shown – there is no solid evidence that it increases endurance in athletes. What actually improves endurance is regular training, adequate recovery and balanced nutrition.

Schisandra is traditionally used in Russia as a tonic for mental and physical fatigue. Evidence base in chronic fatigue: small RCTs with small samples and heterogeneous results. EMA HMPC 2024 recognises «traditional use for symptoms of weakness» without requiring evidence. NICE ME/CFS 2021 (NG206) recommends pacing for chronic fatigue; schisandra is not mentioned. If schisandra was recommended for persistent fatigue without workup, consider seeking a second opinion.

Schisandra (Schisandra chinensis) is a herbal adaptogen; extracts of its berries and seeds are sold in supplements as an aid for memory, focus and mental performance. No convincing benefit has been shown for this use: there is no solid human research on its effect on memory or concentration. The plant itself is generally well tolerated at usual doses, but its value as a cognitive enhancer is unproven. Memory and attention respond most reliably to regular sleep, physical activity and treating the conditions that get in the way of focus, such as iron deficiency, anxiety or depression.

Schisandra is sold as a «natural anti-stress» promising tonic effect without drowsiness. No evidence base: no significant RCTs with anxiety and stress scale endpoints. EMA HMPC 2024 does not include «stress reduction» in approved traditional indications. NICE 2022 and SEP 2014 list SSRIs and CBT for anxiety disorders; schisandra is not mentioned. If schisandra was recommended for clinically significant anxiety, consider seeking a second opinion.